Isabel Kalofonos

CRNX

Isabel Kalofonos serves as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$137.5K

Net Position

Net Seller

$137.5K

Companies Traded

CRNX

Active Period

Jan 2026

1 total trades

Most Recent

Sell CRNX

Jan 5, 2026 · $137.5K

Isabel Kalofonos's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)

Buys

0 · $0.00

Sells

1 · $137.5K

Total Shares Bought

Total Shares Sold

2,500

CRNX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 5, 2026	Sell	2,500	$55.00	$137.5K	0

Related Insiders

Jeff E. Knight

officer: Chief Operating Officer

CRNXSell · Apr 10, 2026

Stephen F. Betz

officer: Chief Scientific Officer

CRNXSell · Mar 18, 2026

Richard Scott Struthers

President & CEO

CRNXSell · Mar 18, 2026

Coelho Rogerio Vivaldi

director

CRNXSell · Mar 13, 2026

Dana Pizzuti

Chief Med and Dev Officer

CRNXSell · Dec 1, 2025

Matthew K Fust

Director

CRNXSell · Sep 26, 2025

Explore More Insider Trading Data

CRNX Insider Trading Activity

View all insider trades at Crinetics Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity